Search research articles
Contact Us
Filters
Showing results (121-130 of 337) with videos related to
Page
of 34
Sort By:
The Journal of Infectious Diseases
|
September 19, 2025
Immune Correlates and Vaccine Immunobridging: Statistical Innovations, Challenges, and Opportunities
Marco Carone, Charles J Wolock, Antonio Olivas-Martinez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 14, 2021
Evaluating Vaccine Efficacy Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Dan-Yu Lin, Yu Gu, Donglin Zeng, et al.
Statistics in Biopharmaceutical Research
|
March 25, 2014
Statistical approaches to analyzing HIV-1 neutralizing antibody assay data
Xuesong Yu, Peter B Gilbert, Catarina E Hioe, et al.
Plos One
|
March 26, 2016
FCGR2C Polymorphisms Associated with HIV-1 Vaccine Protection Are Linked to Altered Gene Expression of Fc-γ Receptors in Human B Cells
Xinxia Peng, Shuying S Li, Peter B Gilbert, et al.
Statistical Methods in Medical Research
|
January 10, 2019
Methods for comparing durability of immune responses between vaccine regimens in early-phase trials
Ted Westling, Michal Juraska, Kelly E Seaton, et al.
Current HIV Research
|
February 3, 2007
HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features
Fusheng Li, Helen Horton, Peter B Gilbert, et al.
Bioinformatics (Oxford, England)
|
May 22, 2021
Super LeArner Prediction of NAb Panels (SLAPNAP): a containerized tool for predicting combination monoclonal broadly neutralizing antibody sensitivity
Brian D Williamson, Craig A Magaret, Peter B Gilbert, et al.
Science Translational Medicine
|
October 23, 2015
Immune correlates of vaccine protection against HIV-1 acquisition
Lawrence Corey, Peter B Gilbert, Georgia D Tomaras, et al.
Statistical Communications in Infectious Diseases
|
January 22, 2024
Study design approaches for future active-controlled HIV prevention trials
Deborah Donnell, Sheila Kansiime, David V Glidden, et al.
The New England Journal of Medicine
|
December 12, 2022
A Covid-19 Milestone Attained - A Correlate of Protection for Vaccines
Peter B Gilbert, Ruben O Donis, Richard A Koup, et al.
Page
of 34
Search research articles
Search
Showing results (121-130 of 337) with videos related to
Sort By:
Page
of 34
The Journal of Infectious Diseases
|
September 19, 2025
Immune Correlates and Vaccine Immunobridging: Statistical Innovations, Challenges, and Opportunities
Marco Carone, Charles J Wolock, Antonio Olivas-Martinez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 14, 2021
Evaluating Vaccine Efficacy Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Dan-Yu Lin, Yu Gu, Donglin Zeng, et al.
Statistics in Biopharmaceutical Research
|
March 25, 2014
Statistical approaches to analyzing HIV-1 neutralizing antibody assay data
Xuesong Yu, Peter B Gilbert, Catarina E Hioe, et al.
Plos One
|
March 26, 2016
FCGR2C Polymorphisms Associated with HIV-1 Vaccine Protection Are Linked to Altered Gene Expression of Fc-γ Receptors in Human B Cells
Xinxia Peng, Shuying S Li, Peter B Gilbert, et al.
Statistical Methods in Medical Research
|
January 10, 2019
Methods for comparing durability of immune responses between vaccine regimens in early-phase trials
Ted Westling, Michal Juraska, Kelly E Seaton, et al.
Current HIV Research
|
February 3, 2007
HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features
Fusheng Li, Helen Horton, Peter B Gilbert, et al.
Bioinformatics (Oxford, England)
|
May 22, 2021
Super LeArner Prediction of NAb Panels (SLAPNAP): a containerized tool for predicting combination monoclonal broadly neutralizing antibody sensitivity
Brian D Williamson, Craig A Magaret, Peter B Gilbert, et al.
Science Translational Medicine
|
October 23, 2015
Immune correlates of vaccine protection against HIV-1 acquisition
Lawrence Corey, Peter B Gilbert, Georgia D Tomaras, et al.
Statistical Communications in Infectious Diseases
|
January 22, 2024
Study design approaches for future active-controlled HIV prevention trials
Deborah Donnell, Sheila Kansiime, David V Glidden, et al.
The New England Journal of Medicine
|
December 12, 2022
A Covid-19 Milestone Attained - A Correlate of Protection for Vaccines
Peter B Gilbert, Ruben O Donis, Richard A Koup, et al.
Page
of 34